Recall archive
4 recalls · page 1 of 1
Reported Jul 8, 2026
Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Sun Pharmaceutical Industries Inc.
Matched: Product · Product details — Failed Impurities/Degradation Specifications
FDA (openFDA drug enforcement)
Reported Oct 21, 2015
QC Quality Choice Loratadine Orally Disintegrating Tablets, USP 10 mg, 10-count tablets per box, Distributed by…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Ohm Laboratories, Inc.
Matched: Brand — Superpotent Drug: Out Of Specification (OOS) result for Assay.
20 more products in this recall
FDA (openFDA drug enforcement)
Reported Jun 24, 2015
Loratadine Orally Disintegrating Tablets USP, 10 mg, Antihistamine, Allergy Relief, 24 Hour, 30 Orally Disintegrating…
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.Ohm Laboratories, Inc.
Matched: Brand — Superpotent Drug: Out Of Specification (OOS) result for Assay.
FDA (openFDA drug enforcement)
Reported Apr 30, 2014
Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg , Loratadine,…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Ohm Laboratories, Inc.
Matched: Brand — Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release…
FDA (openFDA drug enforcement)
RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up